Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by Enzolinion Sep 17, 2019 2:52pm
99 Views
Post# 30136687

RE:SHORTS ARE TRAPPED ! !

RE:SHORTS ARE TRAPPED ! !Guys remember that this stock has been like this for over a almost two years now, who ever is playing with it is controlling it and it doesn't matter if we move 1-20 million shares in a day the sp has either gone down or stays the same!! And the company has come out witha few positive NR. And yes I'm stuck in a ship that has been sinking for a long time and Robert keeps making new statements that don't come true.  I will bet that the deal will not close for the CBD in October watch and see!! He told me that they were partnering with a Canadian LP last Summer and nothing happened guys just read back a year ago to see how people were so excited about Kaly and then they would Dilute more and more payments.  I really feel that if Kaly had anything the spot light would be on them. But hey what do I know do your own DD
Bullboard Posts